Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
60
Frequently Asked Questions
What is Market Cap of Tyra Biosciences Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tyra Biosciences Inc market cap is $646.79M.
What is the 52-week high for Tyra Biosciences Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tyra Biosciences Inc 52 week high is $29.60 as of September 18, 2025.
What is the 52-week low for Tyra Biosciences Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tyra Biosciences Inc 52 week low is $6.42 as of September 18, 2025.
What is Tyra Biosciences Inc stock price today?
Tyra Biosciences Inc stock price today is $12.79.
What was Tyra Biosciences Inc stock price yesterday?
Tyra Biosciences Inc stock price yesterday was $12.15.
What is the PE ratio of Tyra Biosciences Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tyra Biosciences Inc’s P/E ratio is -6.80.
What is the Price-to-Book ratio of Tyra Biosciences Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tyra Biosciences Inc P/B ratio is 2.1406.
What is the 50-day moving average of Tyra Biosciences Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tyra Biosciences Inc 50-day moving average is $11.28.
